Table 2 Clinical characteristics of hospitalized patients and co morbidities identified in hospitalized patients
Variable | 222D | 222G/N/V/A | p |
|---|---|---|---|
Female gender | 33.33% | 66.67% | 0.0884 |
Age (yrs) | 40.5 (26–50.5) | 39.5 (29.5 - 47.5) | 0.9145 |
BMI | 30.57 (26.93 - 33.06) | 35.77 (27.69 - 38.02) | 0.359 |
Evolution time (days) | 7 (4–8) | 4.5 (4–6.5) | 0.2102 |
Heart rate (bpm) | 110 (84.5 - 120) | 108 (90.5 - 117.5) | 0.8702 |
Resp Rate | 28 (22–32) | 24 (22–28) | 0.1951 |
O2 saturation (skin) | 83 (64.5 - 87) | 70 (60–78.5) | 0.0793 |
O2 saturation (blood) | 84 (68.9 - 88.6) | 73.35 (67.6 - 82.6) | 0.168 |
fiO2 | 21 (21–28) | 21 (21–76.25) | 0.1668 |
Kirby score | 192.14 (116.71 - 235.72) | 170.95 (73.5 - 216.43) | 0.2 |
APACHE II | 9 (7–12) | 8 (6.25 - 11) | 0.6787 |
SOFA score | 4 (2–7) | 4 (3.25 - 6) | 0.6646 |
Alkaline phosphatase | 105 (78.25 - 136.75) | 94 (87.5 - 157.5) | 0.5886 |
Platelets | 183500 (128500–236500) | 130500 (107000–176500) | 0.1275 |
Albumin | 3.4 (3–3.87) | 2.9 (2.48 - 3.44) | 0.0509 |
Leukocyte count | 6800 (4650–9150) | 4450 (3300–5050) | 0.0079* |
Neutrophyl count | 5750 (3700–8460) | 3550 (2700–4300) | 0.0079* |
lymphocyte count | 795 (500–1050) | 400 (300–500) | 0.031* |
Hemoglobin | 15.25 (13.3 - 15.85) | 12.65 (10.75 - 13.35) | 0.0017* |
Co morbidities | 222D | 222G/N/V/A | p |
Obesity | 13.89% | 8.33% | 0.9999 |
Diabetes mellitus | 40.5 (26–50.5) | 39.5 (29.5 - 47.5) | 0.9145 |
Systemic arterial hypertension | 5.56% | 33.33% | 0.0278* |
Asthma | 11.11% | 0% | 0.5597 |
Pseudomonas Sp. | 8.33% | 0% | 0.5629 |
Staphylococcus Sp | 11.11% | 8.33% | 0.9999 |
Other | Acinetobacter baumannii, Klepsiella pneumonie, HIV (2), COPD, pulmonary fibrosis, unspecified mycobacteria | Down syndrome |